Additionally, a low baseline frequency of circulating PD1+ CD8+ and NK cells combined with a high expression of soluble PD-L1 (sPD-L1) was negatively associated with the response to PD1/PD-L1 inhibition in patients with advanced NSCLC [88]. Here, CD8A is linked to non-small cell lung carcinoma.